Achilles Therapeutics Selects Netrality’s 401 North Broad for United States Headquarters
Netrality announced today that Achilles Therapeutics, a clinical-stage biopharma company, has leased 7,243 SF of lab space at 401 North Broad.
Netrality announced today that Achilles Therapeutics, a clinical-stage biopharma company, has leased 7,243 SF of lab space at 401 North Broad.